![]() |
|
Names | |
---|---|
IUPAC name
(R)-N'-Hydroxy-N-[(S)-2-indol-3-yl-1-(methylcarbamoyl)ethyl]-2-isobutylsuccinamide
|
|
Other names
Galardin, GM6001
|
|
Identifiers | |
3D model (JSmol)
|
|
Abbreviations | GM6 |
ChEBI | |
ChemSpider | |
DrugBank | |
MeSH | GM6001 |
PubChem CID
|
|
|
|
|
|
Properties | |
C20H28N4O4 | |
Molar mass | 388.47 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Ilomastat (INN), also known as galardin or GM6001 is a broad-spectrum matrix metalloproteinase inhibitor.
Ilomastat is a member of the hydroxamic acid class of reversible metallopeptidase inhibitors. The anionic state of the hydroxamic acid group forms a bidentate complex with the active site zinc.
Examples of enzymes that ilomastat inhibit include thermolysin,peptide deformylase, and anthrax lethal factor endopeptidase (LF) produced by the bacterium Bacillus anthracis.